TLK2 and breast cancer: However, these cell lines typically do not harbour high TLK2 amplifications, and TCGA copy-number data suggest that TLK2 amplifications are much more frequent in ER-positive than negative breast cancers, 10.5% versus 2.9% (Supplementary Fig. 1b).